FDAAPP / ONE TIME

When will the FDA approve Intellia Therapeutics' lonvo-z?

Before July 2027Before October 2027Before 2028

Kalshi

Loading chart…

$3,565 vol

30%Yes —No —

PriceContractsTotal

Trade YesLast 30¢

No resting orders on this market.

OutcomeChanceBuy

BJBefore July 2027

30%▼ 2

Yes 30¢No 70¢

BOBefore October 2027

53%

Yes 53¢No 47¢

B2Before 2028

72%▲ 2

Yes 72¢No 28¢

Resolves Yes if the FDA approves Lonvoguran Ziclumeran (lonvo-z) for Hereditary Angioedema for marketing before Jul 1, 2027, then the market resolves to Yes.

View full rules Help centerReport Insider Trading

When will the FDA approve Intellia Therapeutics' lonvo-z?

Market Rules